• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE GEVIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE GEVIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-1200-S
Device Problem Unexpected Therapeutic Results (1631)
Patient Problem No Code Available (3191)
Event Date 09/06/2019
Event Type  Injury  
Manufacturer Narrative
Additional suspect medical device components involved: product family: dbs-linear leads upn: (b)(4), model: sc-2202-45, serial: (b)(4), batch: 5137272.Product family: dbs-extension, upn: (b)(4), model: nm-3138-55, serial: (b)(4), batch: 7053779.The devices have not been returned for evaluation, therefore a failure analysis of the complaint devices could not be completed.A review of the devices history records will be conducted.If there is any further relevant information from that review, a supplemental med watch will be filed.
 
Event Description
A report was received that patient was not receiving adequate stimulation.The physician decided to schedule two separate appointments with the patient for reprogramming and troubleshooting.Post the reprogramming appointments patient still experienced inadequate stimulation and the physician decided to explant the ipg, right lead and extension, and replace them.Patient experienced a small brain bleed post operatively.He was subsequently discharged to an impatient rehabilitation hospital and is now home doing well.
 
Event Description
A report was received that patient was not receiving adequate stimulation.The physician decided to schedule two separate appointments with the patient for reprogramming and troubleshooting.Post the reprogramming appointments patient still experienced inadequate stimulation and the physician decided to explant the ipg, right lead and extension, and replace them.Patient experienced a small brain bleed post operatively.He was subsequently discharged to an impatient rehabilitation hospital and is now home doing well.
 
Manufacturer Narrative
The database analysis confirmed that the ipg was functioning properly.The returned ipg passed all test performed and revealed no anomalies.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE GEVIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
MDR Report Key9379696
MDR Text Key168247784
Report Number3006630150-2019-06830
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729984443
UDI-Public08714729984443
Combination Product (y/n)N
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 03/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/07/2021
Device Model NumberDB-1200-S
Device Catalogue NumberDB-1200-S
Device Lot Number738310
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/02/2019
Initial Date Manufacturer Received 11/01/2019
Initial Date FDA Received11/26/2019
Supplement Dates Manufacturer Received03/04/2020
Supplement Dates FDA Received03/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
-
-